Search Results - Hubing Shi

Pan-Cancer Analysis Reveals Alternative Splicing Characteristics Associated With Immune-Related Adverse Events Elicited by Checkpoint Immunotherapy by Xiujing He, Jing Yu, Hubing Shi

Connect to this object online.

Editorial: Targeting the PD-1/PD-L1 cancer immune evasion axis: Challenges and emerging strategies, Volume II by Xiujing He, Jie Xu, Huan Meng, Hubing Shi

Connect to this object online.

Management of Adverse Events in Cancer Patients Treated With PD-1/PD-L1 Blockade: Focus on Asian Populations by Jiqiao Yang, Jiqiao Yang, Jiqiao Yang, Xiujing He, Xiujing He, Qing Lv, Qing Lv, Jing Jing, Hubing Shi, Hubing Shi

Connect to this object online.

Editorial: Targeting the PD-1/PD-L1 Cancer Immune Evasion Axis: Challenges and Emerging Strategies by Yiting Wang, Yiting Wang, Hubing Shi, Huan Meng, Jie Xu

Connect to this object online.

Editorial: Public health, public health education, and their future prospects by Yusha Wang, Yusha Wang, Yihui Du, Hubing Shi, Xuelei Ma

Connect to this object online.

Prediction of immunotherapy response of bladder cancer with a pyroptosis-related signature indicating tumor immune microenvironment by Zihan Xu, Yujie Zhao, Yong Zhang, Xiaowei Liu, Linlin Song, Meixu Chen, Guixiu Xiao, Xuelei Ma, Hubing Shi

Connect to this object online.

The biological impact of deuterium and therapeutic potential of deuterium-depleted water by Jiao Qu, Jiao Qu, Yufei Xu, Shuang Zhao, Ling Xiong, Jing Jing, Su Lui, Juan Huang, Hubing Shi

Connect to this object online.